The Evolution of Gene Expression Studies in Drug Safety Assessment

REFERENCES

• Afshari C. A., Nuwaysir E. F., Barrett J. C. Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation. Cancer Res. 1999; 59: 4759–4760, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Barrass N. C., Price R. J., Lake B. G., Orton T. C. Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liver. Carcinogenesis 1993; 14: 1451–1456, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Baker V. A., Harries H. M., Waring J. F., Duggan C. M., Ni H. N., Jolly R. A., Yoon L. W., DeSouza A. T., Schmid J. E., Brown R. H., Ulrich R. G., Rockett J. C. Clofibrate-induced gene expression changes in rat liver: A cross-laboratory analysis using membrane cDNA arrays. Environmen. Health Perspect. 2004; 112: 428–438, [CSA]
   PubMed Web of Science ®Google Scholar
• Bisgaard H. C., Nagy P., Santoni-Rugiu E., Thorgeirsson S. S. Proliferation, apoptosis, and induction of hepatic transcription factors are characteristics of the early response of biliary epithelial (oval) cells to chemical carcinogens. Hepatology 1996; 23: 62–70, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Burczynski M. E., McMillian M., Ciervo J., Parker J. B., Dunn R. T., Hicken S., Farr S., Johnson M. D. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol. Sci. 2000; 58: 399–415, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Chevalier S., Roberts R A. Altered mRNA and protein expression in non-genotoxic hepatocarcinogenesis. Comments on Toxicology 2001; 7: 317–331, [CSA]
   Google Scholar
• Columbano A., Endoh T., Denda A., Noguchi O., Nakae D., Hasegawa K., Ledda-Columbano G. M., Zedda A. I., Konishi Y. Effects of cell proliferation and cell death (apoptosis and necrosis) on the early stages of rat hepatocarcinogenesis. Carcinogenesis 1996; 17: 395–400, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Cosulich S., Roberts R. Suppression of apoptosis by nongenotoxic carcinogens. Apoptosis in Toxicology, R. Roberts. Taylor & Francis, London 2000; 169–186
   Google Scholar
• Crosby L. M., Hyder K. S., DeAngelo A. B., Kepler T. B., Gaskill B., Benavides G. R., Yoon L., Morgan K. T. Morphologic analysis correlates with gene expression changes in cultured F344 rat mesothelial cells. Toxicol. & Appl. Pharmacol. 2000; 169: 205–221, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Crunkhorn S. E., Plant K. E., Gibson G. G., Kramer K., Lyon J., Lord P. G., Plant N. J. Gene expression changes in rat liver following exposure to liver growth agents: Role of Kupffer cells in xenobiotic-mediated liver growth. Biochem. Pharmacol. 2004; 67: 107–118, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Farber E. Clonal adaptation during carcinogenesis. Biochem. Pharmacol. 1990; 39: 1837–1846, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Farber E., Rubin H. Cellular adaptation in the origin and development of cancer. Cancer Res. 1991; 51: 2751–2761, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Farr S., Dunn R. T. Gene expression applied to toxicology. Toxicol. Sci. 1999; 50: 1–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Freeman T. High throughput gene expression screening: Its emerging role in drug discovery. Med. Res. Rev. 2000; 20: 197–202, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Frueh F. W., Zanger U. M., Meyer U. A. Extent and character of Phenobarbital-mediated changes in gene expression in the liver. Molecular Pharmacol. 1997; 51: 363–369, [CSA]
   PubMedGoogle Scholar
• Garcia-Allan C., Loughlin J., Orton T., Lord P. Changes in protein and mRNA levels of growth factor/growth factor receptors in rat livers after administration of phenobarbitone and methylclofenapate. Arch. Toxicol. 1997; 71: 409–415, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Garcia-Allan C., Lord P. G., Loughlin J. M., Orton T. C., Sidaway J. E. Identification of phenobarbitone-modulated genes in mouse liver by differential display. J. Biochem. & Molecular Toxicol. 2000; 14: 65–72, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Gerhold D., Lu M., Xu J., Austin C., Caskey C. T., Rushmore T. Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays. Physiol. Genomics 2001; 5: 161–170, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Greene N. Computer software for risk assessment. J. Chem. Informatics & Comp. Sci. 1997; 37: 148–150, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Greene N., Judson P. N., Langowski J. J., Marchant C A. Knowledge-based expert systems for toxicity prediction: DEREK, StAR and METEOR, SAR QSAR. Environ. Res. 1998; 10: 299–314, [CSA]
   Google Scholar
• Hamadeh H. K., Bushel P. R., Jayadev S., Martin K., DiSorbo O., Sieber S., Bennett L., Tennant R., Stoll R., Barrett J. C., Blanchard K., Paules R. S., Afshari C. A. Gene expression analysis reveals chemical-specific profiles. Toxicol. Sci. 2002; 67: 219–231, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Harries H. M., Fletcher S. T., Duggan C. M., Baker V. A. The use of genomics technology to investigate gene expression changes in cultured human liver cells. Toxicol. In Vitro 2001; 15: 399–405, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hayes K. R., Bradfield C A. Advances in toxicogenomics. Chem. Res. Toxicol. 2005; 18: 403–414, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hsieh L. L., Peraino C., Weinstein I. B. Expression of endogenous retrovirus-like sequences and cellular oncogenes during Phenobarbital treatment and regeneration in rat liver. Cancer Res. 1988; 48: 265–269, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hsieh L. L., Shinozuka H., Weinstein I. B. Changes in expression of cellular oncogenes and endogenous retrovirus-like sequences during hepatocarcinogenesis induced by a peroxisome proliferator. Br. J. Cancer 1991; 84: 815–819, [CSA]
   Google Scholar
• Johnson D. E., Wolfgang H. I. Predicting human safety: Screening and computational approaches. Drug Discovery Today 2000; 5: 445–454, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kasper P., Oliver G., Silva Lima B., Singer T., Tweats D. Joint EFPIA/CHMP SWP workshop: The emerging use of omic technologies for regulatory non-clinical safety testing. Pharmacogenomics 2005; 6: 181–184, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Kier L D., Neft R., Tang L., Suizu R., Cook T., Onsurez K., Tiegler K., Sakai Y., Ortiz M., Nolan T., Sankar U., Li A. P. Applications of microarrays with toxicologically relevant genes (tox genes) for the evaluation of chemical toxicants in Sprague Dawley rats in vivo and human hepatocytes in vitro. Mutation Res. 2004; 549: 101–113, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kind C. N. The application of in-situ hybridization and immuno–histochemistry to problem resolution in drug development. Toxicol. Lett 2000; 112–113: 487–492, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347: 645–650, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lash L. H., Hines R. N., Gonzalez F. J., Zacharewski T. R., Rothstein M. A. Genetics and susceptibility to toxic chemicals: Do you (or should you) know your genetic profile?. J. Pharmacol. Exp. Ther. 2003; 305: 403–409, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lawrence J. W., Li Y., Chen S., DeLuca J. G., Berger J. P., Umbenhauer D. R., Moller D. E., Zhou G. Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expression. J. Biol. Chem. 2001; 276: 31521–31527, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lesko L. J., Salerno R. A., Spear B. B., Anderson D. C., Anderson T., Brazell C., Collins J., Dorner A., Essayan D., Gomez-Mancilla B., Hackett J., Huang S. M., Ide S., Killinger J., Leighton J., Mansfield E., Meyer R., Ryan S. G., Schmith V., Shaw P., Sistare F., Watson M., Worobec A. Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: Report of the first FDA-PWG-PhRMA-DruSafe Workshop. J. Clin. Pharmacol. 2003; 43: 342–358, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Liang P., Pardee A. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992; 257: 967–971, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lord P. G., Barne K. A., Kramer K., Bacon E. J., Mooney J., O'Brien S., Bugelski P. J. cDNA microarrays in investigative toxicology: A study of differential gene expression in compound induced cardiac hypertrophy. Comments on Toxicology 2001; 7: 381–392, [CSA]
   Google Scholar
• Lord P. G. Progress in applying genomics in drug development. Toxicol. Lett. 2004; 149: 371–375, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Macgregor J. T., Farr S., Tucker J. D., Heddle J. A., Tice R. R., Turteltaub K. W. New molecular endpoints and methods for routine toxicity testing. Fundam. Appl. Toxicol. 1995; 26: 156–173, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Maniatis T., Fritsch E. F., Sambrook J. Molecular cloning: A laboratory manual. Cold Spring Harbor, Cold Spring Harbor Laboratory. 1981
   Google Scholar
• Mattes W. B., Pettit S. D., Sansone S.-A., Bushel P. R., Waters M. D. Database development in toxicogenomics: Issues and efforts. Environ. Health Persp. 2004; 112: 495–505, [CSA]
   PubMed Web of Science ®Google Scholar
• McMillian M., Nie A. Y., Parker J. B., Leone A., Kemmerer M., Bryant S., Herlich J., Yieh L., Bittner A., Liu X., Wan J., Johnson M. D. Inverse gene expression patterns for macrophage activating hepatotoxicants and peroxisome proliferators in rat liver. Biochem. Pharmacol. 2004; 67: 2141–2165, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Milano J., McKay J., Dagenais C., Foster-Brown L., Pognan F., Gadient R., Jacobs R. T., Zacco A., Greenberg B., Ciaccio P. J. Modulation of Notch processing by γ -secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicol. Sci. 2004; 82: 341–358, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Mori C., Komiyama M., Adachi T., Sakurai K., Nishimura D., Takashima K., Todaka E. Application of toxicogenomic analysis to risk assessment of delayed long-term effects of multiple chemicals, including endocrine disruptors in human fetuses. Environ. Health Persp. 2003; 111: 7–13, [CSA]
   Google Scholar
• Nadadur S. S., Schladweiler M. C. J., Kodavanti U. P. A pulmonary rat gene array for screening altered expression profiles in air pollutant-induced lung injury. Inhalation Toxicol. 2000; 12: 1239–1254, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Nuwaysir E. F., Bittner M., Trent J., Barrett J. C., Afshari C. A. Microarrays and toxicology: The advent of toxicogenomics. Mol. Carcinogen. 1999; 24: 153–159, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Oberemm A., Onyon L., Gundert-Remy U. How can toxicogenomics inform risk assessment?. Toxicol. Appl. Pharmacol. 2005; 207: 592–598, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Orton T. C., Doughty S. E., Kalinowski A. E., Lord P. G., Wadsworth P. F. Expression of growth factors and growth factor receptors in the liver of C57BL/10J mice following administration of phenobarbitone. Carcinogenesis 1996; 17: 973–981, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Rumsby P. C., Davies M. J., Price R. J., Lake B. G. Effect of some peroxisome proliferators on transforming growth factor-β 1 gene expression and insulin-like growth factor II/mannose-6-phosphate receptor gene expression in rat liver. Carcinogenesis 1994; 15: 419–421, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Pennie W. D., Kimber I. Toxicogenomics; transcript profiling and potential application to chemical allergy. Toxicol. In Vitro 2002; 16: 319–326, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Pennie W. D., Woodyatt N. J., Aldridge T. C., Orphanides G. Application of genomics to the definition of the molecular basis for toxicity. Toxicol. Lett. 2001; 120: 353–358, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Pennie W., Pettit S. D., Lord P. G. Toxicogenomics in risk assessment: An overview of an HESI collaborative research program. Environ. Health Persp. 2004; 112: 417–419, [CSA]
   PubMed Web of Science ®Google Scholar
• Pennie W., Tugwood J. D., Oliver G. J., Kimber I. The principles and practices of toxicogenomics: Applications and opportunities. Toxicol. Sci. 2000; 54: 277–283, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Peters J. M., Cattley R. C., Gonzalez F. J. Role of PPARα in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis 1997; 18: 2029–2033, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Peters J. M., Aoyama T., Cattley R. C., Nobumitsu U., Hashimoto T., Gonzalez F. J. Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver. Carcinogenesis 1998; 19: 1989–1994, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Peterson R. L., Casciotti L., Block L., Goad M. E., Tong Z., Meehan J. T., Jordan R. A., Vinlove M. P., Markiewicz V. R., Weed C. A., Dorner A. J. Mechanistic toxicogenomic analysis of WAY-144122 administration in Sprague-Dawley rats. Toxicol. Appl. Pharmacol. 2004; 196: 80–94, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Petricoin E. F., Hackett J. L., Lesko L. J., Puri R. K., Gutman S. I., Chumakov K., Woodcock J., Feigal D. W., Zoon K. C., Sistare F. D. Medical applications of microarray technologies: A regulatory science perspective. Nature Genetics Suppl. 2002; 32: 474–479, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Plant N., Barber P., Hornton E., Cockburn C.-L., Gibson G., Bugelski P., Lord P. Differential gene expression in rats following subacute exposure to the anti-convulsant sodium valproate. Toxicol. Appl. Pharmacol. 2002; 183: 127–134, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Rockett J. C., Esdaile D. J., Gibson G. G. Differential gene expression in drug metabolism and toxicology: Practicalities, problems and potential. Xenobiotica 1999; 29: 655–691, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Rockett J. C., Swales K. E., Esdaile D. J., Gibson G. G. Use of suppression-PCR subtractive hybridization to identify genes that demonstrate altered expression in male rat and guinea pig livers following exposure to Wy-14,643, a peroxisome proliferator and non-genotoxic hepatocarcinogen. Toxicology 2000; 144: 13–29, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Rodi C. P., Bunch R. T., Curtiss S. W., Kier L. D., Cabonce M. A., Davila J. C., Mitchell M. D., Alden C. L., Morris D. L. Revolution through genomics in investigative and discovery toxicology. Toxicol. Pathol. 1999; 27: 107–110, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Schena M., Heller R. A., Theriault T. P., Konrad K., Lachenmeier E., Davis R. W. Microarrays: Biotechnology's discovery platform for functional genomics. Trends Biotech. 1998; 16: 301–306, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Schulte-Hermann R. Adaptive liver growth induced by xenobiotic compounds: Its nature and mechanism. Arch. Toxicol. S. 1979; 2: 113–124, [CSA]
   Google Scholar
• Schulte-Hermann R., Bursch W., Marian B., Grasl-Kraupp B. Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens. IARC scientific publications 1999; 146: 273–285, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Searfoss G. H., Jordan W. J., Calligaro D. O., Galbreath E. J., Schirtzinger L. M., Berridge B. R., Gao H., Higgins M. A., May P. C., Ryan T. P. Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional γ -secretase inhibitor. J. Biol. Chem. 2003; 278: 46107–46116, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Stevens J. L., Liu H., Halleck M., Bowes R. C., Chen Q. M., van de Water B. Linking gene expression to mechanisms of toxicity. Toxicol. Letts. 2000; 112–113: 479–486, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Suter L., Babiss L. E., Wheeldon E. B. Toxicogenomics in predictive toxicology in drug development. Chem. Biol., 11: 161–171, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Thai S.-F., Allen J. W., DeAngelo A. B., George M. H., Fuscoe J. C. Detection of early gene expression changes by differential display in the livers of mice exposed to dichloroacetic acid. Carcinogenesis 2001; 22: 1317–1322, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Roberts R. A. A PPAR-alpha cDNA cloned from guinea pig liver encodes a protein with similar properties to the mouse PPARa: Implications for species differences in response to peroxisome proliferators. Arch. Toxicol. 1998; 72: 169–177, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Ulrich R. G. The toxicogenomics of nuclear receptor agonists. Curr. Op. Chem. Biol. 2003; 7: 505–510, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ulrich R., Friend S. H. “Toxicogenomics and drug discovery: Will new technologies help us produce better drugs?”. Nature Reviews. Drug Discovery 2002; 1: 84–88, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ward J., Peters J., Perella C., Gonzalez F. Receptor and nonreceptor-mediated organ specific toxicity of DEHP in PPAR-alpha null mice. Toxicol. Pathol. 1998; 26: 240–246, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Waring J. F., Gum R., Morfitt D., Jolly R. A., Ciurlionis R., Heindel M., Gallenberg L., Buratto B., Ulrich R. G. Identifying toxic mechanisms using DNA microarrays: Evidence that an experimental inhibitor of cell adhesion molecule expression signals through the aryl hydrocarbon nuclear receptor. Toxicology 2002; 181–182: 537–550, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Waring J. F., Ciurlionis R., Jolly R. A., Heindel M., Ulrich R. G. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol. Lett. 2001a; 120: 359–368, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Waring J. F., Jolly R. A., Ciurlionis R., Lum P. Y., Praestgaard J. T., Morfitt D. C., Buratto B., Roberts C., Schadt E., Ulrich R. G. Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol. Appl. Pharmacol. 2001b; 175: 28–42, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Woodyatt N., Lambe K., Myers K., Tugwood J., Roberts R. The peroxisome proliferator (PP) response element (PPRE) upstream of the human acyl CoA oxidase gene is inactive in a sample human population: Significance for species differences in response to PPs. Carcinogenesis 1999; 20: 369–375, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Yamazaki K., Kuromitsu J., Tanaka I. Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator-activated receptor α agonists. Biochem. Biophys. Res. Commun. 2002; 290: 1114–1122, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar